CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]
Net income/(loss)	$ 4,852	$ (3,411)
Depreciation and tooling amortization	5,678	5,669
Other amortization	(853)	(876)
(Gain)/Loss on Extinguishment of Debt	0	121
Held-for-sale impairment charges	0	32
Provision for/(Benefit from) credit losses and insurance losses	349	(70)
Pension and other postretirement employee benefits (“OPEB”) expense/(income) (Note 13)	1,026	(595)
Equity method investment dividends received in excess of (earnings)/losses and impairments	(71)	2,975
Foreign currency adjustments	(99)	(71)
Net realized and unrealized (gains)/losses on cash equivalents, marketable securities, and other investments	187	7,365
Net (gain)/loss on changes in investments in affiliates	(19)	137
Stock compensation	350	277
Provision for/(Benefit from) deferred income taxes	(45)	(1,557)
Decrease/(Increase) in finance receivables (wholesale and other)	(1,234)	(6,601)
Decrease/(Increase) in accounts receivable and other assets	(2,965)	(2,370)
Decrease/(Increase) in inventory	(4,229)	(4,160)
Increase/(Decrease) in accounts payable and accrued and other liabilities	9,195	8,453
Other	304	357
Net cash provided by/(used in) operating activities	12,426	5,675
Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]
Capital spending	(5,941)	(4,801)
Acquisitions of finance receivables and operating leases	(40,162)	(32,988)
Collections of finance receivables and operating leases	33,726	35,676
Proceeds from sale of business	0	435
Purchases of marketable securities and other investments	(5,899)	(14,115)
Sales and maturities of marketable securities and other investments	10,384	16,208
Settlements of derivatives	(207)	233
Payments to Acquire Equity Method Investments	(1,615)	(349)
Other	(505)	326
Net cash provided by/(used in) investing activities	(10,219)	625
Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]
Cash payments for dividends and dividend equivalents	(4,394)	(1,410)
Purchases of common stock	0	0
Net changes in short-term debt	(942)	1,650
Proceeds from issuance of long-term debt	36,582	32,855
Payments of long-term debt	(31,819)	(37,395)
Other	(226)	(244)
Net cash provided by/(used in) financing activities	(799)	(4,544)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect [Abstract]
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(114)	(772)
Net increase/(decrease) in cash, cash equivalents, and restricted cash	1,294	984
Cash, cash equivalents, and restricted cash at beginning of period (Note 7)	25,340	20,737
Cash, cash equivalents, and restricted cash at end of period (Note 7)	$ 26,634	$ 21,721